Rolf Hilgenfeld

Rolf Hilgenfeld publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Rolf Hilgenfeld sits on this spectrum.

Rolf Hilgenfeld D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Rolf Hilgenfeld sits on this spectrum.

Overview

Best Publications

• Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

  Linlin Zhang;Daizong Lin;Xinyuanyuan Sun;Ute Curth

  3248
  Citations

• Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs

  Kanchan Anand;John Ziebuhr;Parvesh Wadhwani;Jeroen R. Mesters

  2019
  Citations

• The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

  Haitao Yang;Maojun Yang;Yi Ding;Yiwei Liu

  1100
  Citations

• C-h⋯π-interactions in proteins

  Maria Brandl;Manfred S. Weiss;Andreas Jabs;Jürgen Sühnel

  837
  Citations

• Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases

  Haitao Yang;Weiqing Xie;Xiaoyu Xue;Xiaoyu Xue;Kailin Yang;Kailin Yang

  773
  Citations

• Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein

  Jian Lei;Yuri Kusov;Rolf Hilgenfeld

  759
  Citations

• Crystal structure of active elongation factor Tu reveals major domain rearrangements

  Harald Berchtold;Ludmila Reshetnikova;Ludmila Reshetnikova;Christian O. A. Reiser;Norbert K. Schirmer

  751
  Citations

• From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

  Rolf Hilgenfeld

  725
  Citations

• Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain.

  Kanchan Anand;Gottfried J. Palm;Jeroen R. Mesters;Stuart G. Siddell

  706
  Citations

• α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment

  Linlin Zhang;Daizong Lin;Yuri Kusov;Yong Nian

  564
  Citations

• The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors

  Susanne Pfefferle;Julia Schöpf;Manfred Kögl;Caroline C. Friedel;Caroline C. Friedel

  459
  Citations

• Non-proline cis peptide bonds in proteins

  Andreas Jabs;Manfred S Weiss;Rolf Hilgenfeld

  422
  Citations

• Accessory proteins of SARS-CoV and other coronaviruses

  Ding Xiang Liu;To Sing Fung;Kelvin Kian Long Chong;Aditi Shukla

  421
  Citations

• Structure and functionality in flavivirus NS-proteins: Perspectives for drug design

  Michela Bollati;Karin Alvarez;René Assenberg;Cécile Baronti

  416
  Citations

• From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses.

  Rolf Hilgenfeld;Malik Peiris

  408
  Citations

• Utility of homology models in the drug discovery process.

  Alexander Hillisch;Luis Felipe Pineda;Rolf Hilgenfeld

  401
  Citations

• Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.

  Jian Lei;Guido Hansen;Christoph Nitsche;Christian D. Klein

  363
  Citations

• Conformational Antagonism between Opposing Active Sites in a Bifunctional RelA/SpoT Homolog Modulates (p)ppGpp Metabolism during the Stringent Response

  Tanis Hogg;Undine Mechold;Horst Malke;Mike Cashel

  360
  Citations

• Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.

  Jeroen R Mesters;Cyril Barinka;Weixing Li;Takashi Tsukamoto

  352
  Citations

• X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.

  Sebastian Günther;Patrick Y. A. Reinke;Yaiza Fernández-García;Julia Lieske

  336
  Citations